Substance Abuse & Addiction
Search All News
Smithers Center at Columbia University Irving Medical Center provides evidence-based care to individuals seeking treatment for substance use disorders and co-occurring mental health conditions.
In a Phase 2a clinical trial, Columbia researchers found that the drug AEFO117 significantly reduced the effects of cannabis in daily cannabis smokers.
A Columbia study finds that adolescents who use cannabis recreationally are two to four times as likely to develop psychiatric disorders then teens who don’t use cannabis at all.
- November 8, 2022
This year’s Eric D. Hadar Distinguished Lecturer, Dr. Rajita Sinha, will present “Can We Rescue Stress and Trauma Related Pathophysiology in Addiction to Improve Treatment Outcomes?” on Nov. 16, 2022.
- October 26, 2022
Patients who participate in fewer than two visits early in treatment are at risk for relapse, overdose, and possible death.
- September 15, 2022
Columbia psychiatrist Nasir Naqvi, MD, PhD, discusses which treatments for alcohol use disorder are most effective and the importance of community and support in treating AUD.
Source:The New York TimesMay 19, 2022
Jermaine Jones, PhD, a neuroscientist at Columbia, teaches people to rouse individuals experiencing a fentanyl overdose by giving them a firm rub with their knuckles in the center of the chest.
Source:Associated PressApril 12, 2022
Katherine Keyes, director of Columbia’s Psychiatric Epidemiology Training Program, testified at an ongoing trial against three major pharmaceutical companies regarding the opioid epidemic.
- November 3, 2021
As more states legalize cannabis for medical or recreational purposes its use during pregnancy is increasing, along with the potential for abuse or dependence.
- October 27, 2021
This year’s Eric D. Hadar Lecture will take place on November 3, 2021 with Dr. Steven Shoptaw, who will present, “Medications as Foundation for Stimulant Use Disorder Treatment: Is it Time?”